Goodwill Pharma Plc. has increased its share capital in the form of a private placement raising HUF 1.3 billion new capital from investors. The Budapest Stock Exchange registered the new shares in the Xtend category on December 20, 2023.

Goodwill Pharma Plc. is a Hungarian integrated pharmaceutical public limited company established in 1997. The Company has manufacturing capacity in Hungary and Serbia and sells products in 10 other countries through subsidiaries and distribution partners focusing on Central and Eastern Europe and the Balkans. The Company’s own-manufactured and licensed medicines and dietary supplements play a growing role in its sales activities.

CMBP (IMAP Hungary) provided financial advisory to Godwill Pharma Plc. for the private placement and the registration of shares in the Xtend category of the Budapest Stock Exchange.